Sorry, this event is SOLD OUT, and registration is now closed. By invitation only. This event is exclusively for Biotech companies doing business in the Frederick region. Call 301.662.4164 x1 to request an invitation, or check this page for updated event information.
Get a peek from two of NCI-Frederick's leading researchers on intracellular delivery of therapeutic proteins through targeted delivery of proteins using virus-like particles, regenerative medicine and stem cells. Plus, hear about what it takes to find partnering opportunties at Ft. Detrick.
Left to Right: Deb K. Chatterjee, Ph.D.; Jonathan R. Keller, Ph.D.; Frank Blanchard
Deb K. Chatterjee, Ph.D. - Associate Director, Protein Expression Laboratory
Dr. Chatterjee received his B.Sc (Chemistry Hons) and Ph.D. (Biochemistry) degrees from the University of Calcutta, India. His postdoctoral work, in the laboratory of Prof. A.M. Chakrabarty at the University of Illinois at Chicago, involved genetic engineering of Pseudomonas and Caulobacter strains for their ability to degrade toxic aromatic compounds including chlorobenzoates, Agent Orange, toluene, and benzoates.
Jonathan R. Keller, Ph.D. - Head, Hematopoiesis and Stem Cell Biology Section
Dr. Jonathan Keller obtained his Ph.D. under the direction of James Ihle at George Washington University, where he characterized and purified interleukin 3. He has a longstanding interest in the molecular and cellular regulation of hematopoietic cell growth and differentiation.
Frank Blanchard - Director of Public Affairs
Frank Blanchard has been Director of Public Affairs for SAIC-Frederick since 2006. He is responsible for public facing communications and external relations with the community. He also supports major national initiatives undertaken by SAIC-Frederick on behalf of its customer, the National Cancer Institute at Frederick